Faeth Therapeutics, Inc. Common Stock FTH
$12.68
-42.49%
at last close
Analyst Consensus
- Consensus Rating
- Buy (12 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $57.80
- Implied Upside
- +355.8%
- Price Target Range
- $51.00 – $69.00
- Analysts (12 mo)
- 12
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-04 | GuggenheimMichael Schmidt |
Maintains | Buy | $70 → $69 |
| 2026-10-27 | BTIGJeet Mukherjee |
Reiterates | Buy | $55 |
| 2026-10-16 | William BlairAlethia Young |
Initiates coverage on | Outperform | — |
| 2026-09-16 | GuggenheimBrad Canino |
Initiates coverage on | Buy | $70 |
| 2026-09-14 | LUCID CAPITAL MARKETSDev Prasad |
Initiates coverage on | Buy | $59 |
| 2026-09-09 | TD CowenTara Bancroft |
Initiates coverage on | Buy | — |
| 2026-08-21 | NeedhamGil Blum |
Initiates coverage on | Buy | $56 |
| 2026-08-11 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $60 |
| 2026-08-04 | Jones TradingMatthew Murray |
Initiates coverage on | Buy | $55 |
| 2026-07-31 | Raymond JamesSean McCutcheon |
Initiates coverage on | Outperform | $56 |
| 2026-07-28 | OppenheimerJay Olson |
Initiates coverage on | Outperform | $60 |
| 2026-07-20 | CitizensSilvan Turkcan |
Initiates coverage on | Market outperform | $51 |
| 2026-07-16 | BTIGJeet Mukherjee |
Reiterates | Buy | $55 |
| 2026-06-26 | BairdJack Allen |
Initiates coverage on | Outperform | $57 |
| 2026-06-22 | HC Wainwright & Co.Patrick R. Trucchio |
Initiates coverage on | Buy | $60 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $12.68
- Market Cap
- $569.86 million
- 52-Week Range
- $10.45 – $42.14
- Average Volume
- 477K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.